Physician Assistant · Lafayette, CO
NPI
1114471562
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1000 W South Boulder Rd Ste 200
Lafayette, CO, 80026
Phone (303) 604-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
452 services
Medicare patients, 2024
345
Average age 73
Drug cost, 2024
$899K
1,133 prescriptions
Company payments, 2025
$2,329
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katie E Vieira was code 99213 (office e&m - established), 223 times for 188 patients. In total Katie E Vieira billed 452 services in 10 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 223 | 188 | $58.37 | $13K |
| 99214 Office E&M - Established | Office | 162 | 141 | $83.15 | $13K |
| 99203 Office E&M - New | Office | 22 | 22 | $69.18 | $1,522 |
| 99204 Office E&M - New | Office | 21 | 21 | $110.37 | $2,318 |
By year: 2022 $39K for 562 services; 2023 $31K for 460 services; 2024 $31K for 452 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katie E Vieira prescribed most often to Medicare patients was Pantoprazole Sodium, with 220 prescriptions and refills. In total Katie E Vieira wrote 1,133 Medicare prescriptions that cost $899K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 220 | 559 | 79 | $2,788 |
| Omeprazole Generic | 175 | 448 | 72 | $2,889 |
| Famotidine Generic | 149 | 334 | 61 | $2,436 |
| Dicyclomine Hcl Generic | 51 | 83 | 29 | $1,037 |
| Budesonide Dr Budesonide | 40 | 60 | 18 | $15K |
| Dexlansoprazole Dr Dexlansoprazole | 39 | 70 | 11 | $12K |
| Linzess Linaclotide | 36 | 64 | 18 | $34K |
| Mesalamine Generic | 33 | 69 | Under 11 | $7,785 |
| Esomeprazole Magnesium Generic | 32 | 91 | 14 | $1,589 |
| Desipramine Hcl Generic | 22 | 24 | Under 11 | $389 |
| Lubiprostone Generic | 22 | 33 | Under 11 | $3,322 |
| Xifaxan Rifaximin | 20 | 20 | 17 | $48K |
| Baclofen Generic | 19 | 23 | Under 11 | $194 |
| Stelara Ustekinumab | 18 | 31 | Under 11 | $500K |
| Cholestyramine Cholestyramine (With Sugar) | 17 | 36 | Under 11 | $1,924 |
Brand drugs: 191 claims; generic drugs: 942 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katie E Vieira $2,329 ($2,329 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $618.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $618 |
| Gilead Sciences, Inc. GILD | 14 | $335 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 11 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $213 |
| Ardelyx, Inc. ARDX | 7 | $202 |
| Janssen Biotech, Inc. JNJ | 7 | $150 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $145 |
| Madrigal Pharmaceuticals MDGL | 3 | $139 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $107 |
| Lilly USA, LLC LLY | 5 | $92.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.